Found 0 matching trials
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
NAPilot Immunotherapy Study of Combination Prostate Specific Membrane Antigen...
Location
H. Lee Moffitt Cancer Center & Research Institute
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
PHASE1RATIONALE: Vaccines made from a person's peripheral stem cells may make the...
Location
Jonsson Comprehensive Cancer Center, UCLA
Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer
NAThis study aims to evaluate the imaging characteristics of \[⁶⁸Ga\]Ga-GS24-...
Location
Multiple Locations
Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma
NAIn this prospective study, 68Ga-PSMA integrated PET/MR imaging was applied ...
Location
China, Hubei Province
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
PHASE2In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Location
UCLA / Jonsson Comprehensive Cancer Center
Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer
PHASE1This is a feasibility, exploratory, and proof-of-concept study to evaluate ...
Location
Johns Hopkins Outpatient Center
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan
PHASE2The purpose of this study is to assess the efficacy, tolerability, safety, ...
Location
Novartis Investigative Site
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
PHASE2Background:
Identifying medium- and high-risk prostate cancer early may al...
Location
National Institutes of Health Clinical Center
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE1The overall aim of the trial is to evaluate the safety, tolerability, and p...
Location
City of Hope National Medical Center
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
PHASE1This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Location
City of Hope Medical Center